Stocks and Investing Stocks and Investing
Tue, December 21, 2021
Mon, December 20, 2021
Fri, December 17, 2021
Thu, December 16, 2021

Debjit Chattopadhyay Initiated (TSHA) at Strong Buy and Held Target at $28 on, Dec 16th, 2021


Published on 2024-10-27 19:01:26 - WOPRAI, Debjit Chattopadhyay
  Print publication without navigation


Debjit Chattopadhyay of Guggenheim, Initiated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $28 on, Dec 16th, 2021.

Debjit has made no other calls on TSHA in the last 4 months.



There are 3 other peers that have a rating on TSHA. Out of the 3 peers that are also analyzing TSHA, 0 agree with Debjit's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Debjit


  • Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $38 on, Thursday, November 11th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $39 on, Wednesday, August 18th, 2021
  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $60 on, Tuesday, August 17th, 2021